At the 1974 meeting of the Nordic Council, a committee was set up to review the labelling of medicines which may have effects on the user's driving ability, and thus constitute a traffic hazard. In its final report, the committee emphasizes that the policy to be followed should be a restrictive one, otherwise it might be discredited or its objective might be overreached. The committee divided the drugs into two groups; especially hazardous drugs and potentially hazardous drugs. It then recommends that drugs belonging to the first group are marked by the manufacturer with a symbol indicating that there is a traffic hazard and the drugs belonging to the second group are marked by the pharmacy, when the doctor indicates this on the prescription. Finally, the committee proposes that a permanent Nordic Committee should be set up under the Nordic Council of Medicines; its aim being to evaluate matters relating to the registration of medicines that may constitute a traffic hazard, and to act as a consultant in questions concerning research in this field. /TRRL/

  • Corporate Authors:

    Nordiska Ministerraadet

    Stockholm,   Sweden 
  • Publication Date: 1977


  • Undetermined

Media Info

  • Features: Tables;
  • Pagination: 72 p.

Subject/Index Terms

Filing Info

  • Accession Number: 00189548
  • Record Type: Publication
  • Source Agency: Transport and Road Research Laboratory (TRRL)
  • Report/Paper Numbers: NU-SerienA 1977:11 Monograph
  • Files: ITRD, TRIS
  • Created Date: Apr 12 1979 12:00AM